198 related articles for article (PubMed ID: 10720270)
41. [Neurophysiology of corticobasal degeneration].
Tyvaert L; Cassim F; Derambure P; Defebvre L
Rev Neurol (Paris); 2007 Sep; 163(8-9):779-91. PubMed ID: 17878804
[TBL] [Abstract][Full Text] [Related]
42. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
Bak TH; Crawford LM; Hearn VC; Mathuranath PS; Hodges JR
Neurocase; 2005 Aug; 11(4):268-73. PubMed ID: 16093227
[TBL] [Abstract][Full Text] [Related]
43. Olfactory function in atypical parkinsonian syndromes.
Wenning GK; Shephard B; Hawkes C; Petruckevitch A; Lees A; Quinn N
Acta Neurol Scand; 1995 Apr; 91(4):247-50. PubMed ID: 7625148
[TBL] [Abstract][Full Text] [Related]
44. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
[TBL] [Abstract][Full Text] [Related]
45. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
46. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
[TBL] [Abstract][Full Text] [Related]
47. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
Lass P; Sławek J; Derejko M; Dubaniewicz M
Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
[TBL] [Abstract][Full Text] [Related]
48. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
49. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
Kasashima S; Oda Y
Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
[TBL] [Abstract][Full Text] [Related]
50. Pathophysiology of slow vertical saccades in progressive supranuclear palsy.
Bhidayasiri R; Riley DE; Somers JT; Lerner AJ; Büttner-Ennever JA; Leigh RJ
Neurology; 2001 Dec; 57(11):2070-7. PubMed ID: 11739828
[TBL] [Abstract][Full Text] [Related]
51. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
52. Deterioration of horizontal saccades in progressive supranuclear palsy.
Terao Y; Fukuda H; Shirota Y; Yugeta A; Yoshioka M; Suzuki M; Hanajima R; Nomura Y; Segawa M; Tsuji S; Ugawa Y
Clin Neurophysiol; 2013 Feb; 124(2):354-63. PubMed ID: 22883477
[TBL] [Abstract][Full Text] [Related]
53. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
[TBL] [Abstract][Full Text] [Related]
54. Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases.
Murphy MA; Friedman JH; Tetrud JW; Factor SA
J Clin Neurosci; 2005 Nov; 12(8):941-5. PubMed ID: 16289932
[TBL] [Abstract][Full Text] [Related]
55. [Neuroimaging features in progressive supranuclear palsy and corticobasal degeneration].
Mori E
Rinsho Shinkeigaku; 2002 Nov; 42(11):1158-61. PubMed ID: 12784693
[TBL] [Abstract][Full Text] [Related]
56. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
57. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques.
Giménez-Roldán S; Mateo D; Benito C; Grandas F; Pérez-Gilabert Y
J Neural Transm Suppl; 1994; 42():79-90. PubMed ID: 7964699
[TBL] [Abstract][Full Text] [Related]
58. Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: a prospective study.
Cooper AD; Josephs KA
Parkinsonism Relat Disord; 2009 Jan; 15(1):59-61. PubMed ID: 18328771
[TBL] [Abstract][Full Text] [Related]
59. [Glial abnormalities in progressive supranuclear palsy and corticobasal degeneration].
Zhu MW; Wang LN; Li XH; Gui QP
Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):125-9. PubMed ID: 15132848
[TBL] [Abstract][Full Text] [Related]
60. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease.
Pillon B; Blin J; Vidailhet M; Deweer B; Sirigu A; Dubois B; Agid Y
Neurology; 1995 Aug; 45(8):1477-83. PubMed ID: 7644044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
